Henagliflozin in Patients With Atrial Fibrillation

Clinical trial NCT05252624 · UNKNOWN

Trial details

NCT number: NCT05252624
Sponsor: Beijing Anzhen Hospital
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Atrial Fibrillation

Start date: 2022-09-01
Primary completion: 2023-09-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.